BEIJING -- China's pharmaceutical market is expected to soar to 2.3 trillion yuan ($369.2 billion) by 2020, up from 926.1 billion yuan this year, according to a report.
The Report on China's Pharmaceutical Market 2012, published Friday by the Social Sciences Academic Press, noted that the country's aging population will give rise to increased demand for medicine, while a fast-growing economy is expected to boost both the social insurance level and people's consumption capacities.
According to the report, these factors will help the country's pharmaceutical market expand at an average annual rate of 12 percent by 2020.
The report also pointed out various problems in the country's pharmaceutical industry, noting that many Chinese pharmaceutical companies haven't realized large-scale operation and their shares in the high-end drug market pale in comparison to that of foreign groups.
Moreover, a basic medicine system that ensures commonly-used drugs be sold at production cost has led to a relatively stagnant market for companies that mainly produce such pharmaceutical products.
Related Readings
Pharmaceutical companies seek global solutions
Pharmaceutical plant to relocate after pollution scandal
China beefs up pharmaceutical regulation
Drug makers look East for cooperation
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 130349 
